| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 18.05.
| Shares of United Therapeutics Rank the Lowest in Terms of PEG Ratio in the Biotechnology Industry | | 1 | SmarTrend |
| 15.05.
| Bullish Moving Average Cross by United Therapeutics | | 1 | SmarTrend |
| 09.05.
| Possible Bearish Inside Day Candle Pattern Detected for United Therapeutics | | 1 | SmarTrend |
| 01.05.
| Possible Bearish Inside Day Candle Pattern Detected for United Therapeutics | | 1 | SmarTrend |
| 27.04.
| Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics | | 58 | PR Newswire |
| CHICAGO, April 27, 2012 /PRNewswire/ --Today, Zacks Equity Research discusses the Pharmaceuticals & Biotech Industry, including Eli Lilly (NYSE: LLY), Forest Labs (NYSE: FRX), ViroPharma (Nasdaq:...
Mehr lesen zu:
Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics | |
| 27.04.
| Downgrade Alert for United Therapeutics | | 2 | SmarTrend |
| 26.04.
| UPDATE 1-United Therapeutics 1st-qtr beats estimates | | 1 | Reuters.com |
| 26.04.
| United Therapeutics Corporation Reports First Quarter 2012 Financial Results | | 18 | PR Newswire |
| SILVER SPRING, Md., April26, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March31, 2012.
"I am pleased with...
Mehr lesen zu:
United Therapeutics Corporation Reports First Quarter 2012 Financial Results | |
| 19.04.
| United Therapeutics Corporation To Announce First Quarter 2012 Financial Results Before Market Open On Thursday, April 26, 2012 | | 11 | PR Newswire |
| SILVER SPRING, Md., April 19, 2012 /PRNewswire/ --United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2012 financial results before market open on...
Mehr lesen zu:
United Therapeutics Corporation To Announce First Quarter 2012 Financial Results Before Market Open On Thursday, April 26, 2012 | |
| 15.03.
| UPDATE 1-United Therapeutics sues Sandoz over hypertension drug | | 6 | Reuters.com |
| 15.03.
| United Therapeutics Files Suit Blocking Sandoz ANDA For Generic Remodulin | | 68 | AFX News |
| BASEL (dpa-AFX) - United Therapeutics Corp. (UTHR) Thursday reported filing
a lawsuit against Sandoz Inc. which seeks to block the approval of an
Abbreviated New Drug Application, or ANDA...
Mehr lesen zu:
United Therapeutics Files Suit Blocking Sandoz ANDA For Generic Remodulin | |
| 15.03.
| United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents | | 24 | PR Newswire |
| SILVER SPRING, Md, March 15, 2012 /PRNewswire/ --United Therapeutics Corporation (NASDAQ: UTHR) today announced that it has filed a lawsuit in the U.S. District Court for the District...
Mehr lesen zu:
United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents | |
| 14.02.
| United Therapeutics Corporation Reports 2011 Fourth Quarter and Annual Financial Results | | 30 | PR Newswire |
| SILVER SPRING, Md., Feb.14,2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December31,2011.
"I am pleased...
Mehr lesen zu:
United Therapeutics Corporation Reports 2011 Fourth Quarter and Annual Financial Results | |
| 07.02.
| United Therapeutics Corporation to Announce Fourth Quarter and Annual 2011 Financial Results Before Market Open on Tuesday, February 14, 2012 | | 12 | PR Newswire |
| SILVER SPRING, Md., Feb. 7, 2012 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2011 financial results before market...
Mehr lesen zu:
United Therapeutics Corporation to Announce Fourth Quarter and Annual 2011 Financial Results Before Market Open on Tuesday, February 14, 2012 | |
| 06.02.
| United Therapeutics (UTHR) Receives Paragraph IV from Sandoz for Generic Remodulin | | 6 | StreetInsider.com |
| 06.02.
| United Therapeutics Receives Paragraph IV Notice Letter for Remodulin | | 28 | PR Newswire |
| SILVER SPRING, Md., Feb. 6, 2012 /PRNewswire/ --United Therapeutics Corporation (NASDAQ: UTHR) today announced receipt of a Paragraph IV Certification Notice Letter on February 3, 2012...
Mehr lesen zu:
United Therapeutics Receives Paragraph IV Notice Letter for Remodulin | |
| 27.12.
| United Therapeutics (UTHR) Gets Approval from AFSSAPS for Remodulin | | 2 | StreetInsider.com |
